CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | – | 1,270 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 1,270 | -7.3% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 1,370 | -99.3% | 0.00% | – |
| Q1 2016 | $102,000 | +27.5% | 191,817 | +192.2% | 0.00% | – |
| Q4 2015 | $80,000 | +3900.0% | 65,636 | +3934.2% | 0.00% | – |
| Q3 2015 | $2,000 | -83.3% | 1,627 | -73.9% | 0.00% | – |
| Q2 2015 | $12,000 | -55.6% | 6,240 | -57.6% | 0.00% | – |
| Q1 2015 | $27,000 | -59.7% | 14,712 | -48.0% | 0.00% | – |
| Q4 2014 | $67,000 | +346.7% | 28,277 | +366.3% | 0.00% | – |
| Q3 2014 | $15,000 | -71.2% | 6,064 | -66.6% | 0.00% | – |
| Q2 2014 | $52,000 | – | 18,148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,425,000 | $3,363,000 | 2.66% |
| ACUTA CAPITAL PARTNERS, LLC | 1,228,111 | $2,898,000 | 1.96% |
| Sio Capital Management, LLC | 505,000 | $1,192,000 | 0.94% |
| RA Capital Management | 2,500,000 | $5,900,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,000 | $1,770,000 | 0.30% |
| TFS CAPITAL LLC | 1,295,744 | $3,058,000 | 0.29% |
| EAGLE ASSET MANAGEMENT INC | 12,713,051 | $30,002,000 | 0.17% |
| JW Asset Management, LLC | 52,271 | $123,000 | 0.09% |
| Lombard Odier Asset Management (USA) Corp | 501,444 | $1,183,000 | 0.08% |
| First Heartland Consultants, Inc. | 74,624 | $176,000 | 0.07% |